EurekAlert! - Infectious and Emerging Diseases This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Butterfly effect can double travel of virus-laden droplets
(American Institute of Physics) In Physics of Fluids, investigators from the University of Florida and Lebanese American University carried out detailed computer simulations to test a mathematical theory they developed previously. They found nearly identical exhalations could spread in different directions when miniscule initial variations are substantially amplified by turbulence. This is the so-called butterfly effect. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 29, 2021 Category: Infectious Diseases Source Type: news

Patients with acute myocarditis following mRNA COVID-19 vaccination
This study describes four patients who presented with acute myocarditis after mRNA COVID-19 vaccination. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 29, 2021 Category: Infectious Diseases Source Type: news

Blood clots related to AstraZeneca/Oxford vaccine can be mitigated with early detection
(RCSI) New research has shown that early testing for blood clots in patients who had received the AstraZeneca/Oxford vaccine led to them being treated successfully, highlighting the need for heightened awareness of the risk among doctors. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 29, 2021 Category: Infectious Diseases Source Type: news

Adjuvant developed with NIH funding enhances efficacy of India's COVID-19 vaccine
(NIH/National Institute of Allergy and Infectious Diseases) An adjuvant developed with funding from the National Institutes of Health has contributed to the success of the highly efficacious COVAXIN COVID-19 vaccine, which roughly 25 million people have received to date in India and elsewhere. Adjuvants are substances formulated as part of a vaccine to boost immune responses and enhance a vaccine's effectiveness. COVAXIN was developed and is manufactured in India, which is currently suffering a devastating health crisis due to COVID-19. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 29, 2021 Category: Infectious Diseases Source Type: news

Strategies to speed global vaccine availability
(Columbia University's Mailman School of Public Health) In a new paper experts review the vaccine research and development process and propose areas where reforms could increase access, speed time to market and decrease costs -- from R&D to manufacturing and regulation to the management of incentives like patents and public funding. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 29, 2021 Category: Infectious Diseases Source Type: news

Reported cases of myocarditis in younger men following COVID-19 vaccination are rare; vaccination remains important
(Mayo Clinic) Mayo Clinic researchers are taking a close look at rare cases of inflammation of the heart muscle, or myocarditis, in young men who developed symptoms shortly after receiving the second dose of the Moderna or Pfizer messenger RNA (mRNA) COVID-19 vaccines. Several recent studies suggest that health care professionals should watch for hypersensitivity myocarditis as a rare adverse reaction to being vaccinated for COVID-19. However, researchers stress that this awareness should not diminish overall confidence in vaccination during the current pandemic. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 29, 2021 Category: Infectious Diseases Source Type: news

Hackensack Meridian CDI scientists discover new tuberculosis treatment pathway
(Hackensack Meridian Health) The compound TA-C is metabolized by TB bacteria - weakening the germ from within like a 'Trojan horse' attack (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 29, 2021 Category: Infectious Diseases Source Type: news

Financial barriers to cervical cancer screening
(Mary Ann Liebert, Inc./Genetic Engineering News) Among low-income, uninsured, or publicly insured women ages 25-64 years who were not up to date on cervical cancer screening, 72% perceived financial barriers to screening. The most commonly reported barriers were screening appointment costs (71%) and follow-up/future treatment costs (44%). (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 29, 2021 Category: Infectious Diseases Source Type: news

ACTG announces publication of REPRIEVE sub-study in JAMA Network Open, providing insights into cardiovascular disease risk among people living with HIV
(AIDS Clinical Trials Group) The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, today announced that findings from a sub-study of REPRIEVE (A5332/A5332s, an international clinical trial studying heart disease prevention in people living with HIV) have been published in the Journal of the American Medical Association Network Open. The study found that approximately half of study participants, who were considered by traditional measures to be at low-to-moderate risk of future heart disease, had atherosclerotic plaque in their coronary arteries. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 29, 2021 Category: Infectious Diseases Source Type: news

How two California hospitals prevented the spread of a deadly fungal infection during the pandemic
(Association for Professionals in Infection Control) In the midst of the COVID-19 pandemic, infection preventionists at two Southern California hospitals took extreme measures to stop the spread of a deadly fungus that has emerged in the U.S. and around the world. The two will detail their proactive responses in oral presentations today at the Association for Professionals in Infection Control and Epidemiology's (APIC's), 48th Annual Conference. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 29, 2021 Category: Infectious Diseases Source Type: news

Researchers discover unique 'spider web' mechanism that traps, kills viruses
(McMaster University) Immunologists at McMaster University have discovered a previously unknown mechanism which acts like a spider web, trapping and killing pathogens such as influenza or SARS-CoV-2, the virus responsible for COVID-19. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 29, 2021 Category: Infectious Diseases Source Type: news

UofL researchers lead call to increase genetic diversity in immunogenomics
(University of Louisville) Historically, most large-scale immunogenomic studies - those exploring the association between genes and disease - were conducted with a bias toward individuals of European ancestry. Corey T. Watson, Ph.D., assistant professor in the University of Louisville Department of Biochemistry and Molecular Genetics, is leading a call to actively diversify the genetic resources he and fellow immunogenomics researchers use in their work to advance genomic medicine more equitably. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 29, 2021 Category: Infectious Diseases Source Type: news

COVID-19 news from Annals of Internal Medicine
(American College of Physicians) Members of the ACTIV (Accelerating COVID-19 Therapeutic Interventions and Vaccines) workgroup, a partnership of experts representing government, industry, and academia, describe how nine master protocols for evaluating therapeutic agents for COVID-19 were designed, developed, and launched, and lessons learned that may be useful in meeting the challenges of a future pandemic. Their commentary is published in Annals of Internal Medicine. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 28, 2021 Category: Infectious Diseases Source Type: news

NTU develops rapid malaria test kit that could aid diagnosis in developing countries
(Nanyang Technological University) A team of scientists from Nanyang Technological University, Singapore (NTU Singapore) has developed a test kit for malaria that delivers results in 30 minutes. The kit could facilitate the diagnosis of malaria in the field, as the equipment needed is anticipated to be lightweight, easy-to-use, and able to detect the disease in its early stages. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 28, 2021 Category: Infectious Diseases Source Type: news

The Lancet Inf. Dis.: Coronavac COVID-19 vaccine safe in children and adolescents and triggers antibodies
(The Lancet) Two doses of CoronaVac are safe and provoke a strong antibody response among children and adolescents aged 3-17 years, according to a randomised controlled trial of 550 young people published in The Lancet Infectious Diseases journal. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 28, 2021 Category: Infectious Diseases Source Type: news